vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $40.3M, roughly 1.1× Cambium Networks Corp). Cambium Networks Corp runs the higher net margin — -17.9% vs -90.4%, a 72.5% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -23.2%). Cambium Networks Corp produced more free cash flow last quarter ($-10.8M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -27.2%).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

CMBM vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.1× larger
PACB
$44.6M
$40.3M
CMBM
Growing faster (revenue YoY)
PACB
PACB
+37.0% gap
PACB
13.8%
-23.2%
CMBM
Higher net margin
CMBM
CMBM
72.5% more per $
CMBM
-17.9%
-90.4%
PACB
More free cash flow
CMBM
CMBM
$9.1M more FCF
CMBM
$-10.8M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-27.2%
CMBM

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CMBM
CMBM
PACB
PACB
Revenue
$40.3M
$44.6M
Net Profit
$-7.2M
$-40.4M
Gross Margin
36.6%
37.1%
Operating Margin
-28.4%
-92.3%
Net Margin
-17.9%
-90.4%
Revenue YoY
-23.2%
13.8%
Net Profit YoY
71.0%
-1802.7%
EPS (diluted)
$-0.26
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
PACB
PACB
Q4 25
$44.6M
Q3 25
$38.4M
Q2 25
$39.8M
Q1 25
$37.2M
Q4 24
$40.3M
$39.2M
Q3 24
$44.7M
$40.0M
Q2 24
$45.2M
$36.0M
Q1 24
$47.1M
$38.8M
Net Profit
CMBM
CMBM
PACB
PACB
Q4 25
$-40.4M
Q3 25
$-38.0M
Q2 25
$-41.9M
Q1 25
$-426.1M
Q4 24
$-7.2M
$2.4M
Q3 24
$-34.5M
$-60.7M
Q2 24
$-14.2M
$-173.3M
Q1 24
$-18.4M
$-78.2M
Gross Margin
CMBM
CMBM
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
36.6%
25.6%
Q3 24
43.6%
25.0%
Q2 24
32.5%
16.5%
Q1 24
29.8%
29.1%
Operating Margin
CMBM
CMBM
PACB
PACB
Q4 25
-92.3%
Q3 25
-101.1%
Q2 25
-112.8%
Q1 25
-1154.5%
Q4 24
-28.4%
-390.1%
Q3 24
-69.6%
-160.3%
Q2 24
-27.2%
-488.3%
Q1 24
-33.1%
-209.6%
Net Margin
CMBM
CMBM
PACB
PACB
Q4 25
-90.4%
Q3 25
-98.9%
Q2 25
-105.4%
Q1 25
-1146.8%
Q4 24
-17.9%
6.0%
Q3 24
-77.3%
-151.9%
Q2 24
-31.5%
-481.3%
Q1 24
-39.2%
-201.4%
EPS (diluted)
CMBM
CMBM
PACB
PACB
Q4 25
$-0.11
Q3 25
$-0.13
Q2 25
$-0.14
Q1 25
$-1.44
Q4 24
$-0.26
$-0.44
Q3 24
$-1.22
$-0.22
Q2 24
$-0.51
$-0.64
Q1 24
$-0.66
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$279.5M
Total DebtLower is stronger
$67.6M
Stockholders' EquityBook value
$-3.2M
$5.3M
Total Assets
$173.7M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
PACB
PACB
Q4 25
$279.5M
Q3 25
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Total Debt
CMBM
CMBM
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$67.6M
Q3 24
$67.6M
Q2 24
$68.9M
Q1 24
$63.8M
Stockholders' Equity
CMBM
CMBM
PACB
PACB
Q4 25
$5.3M
Q3 25
$36.1M
Q2 25
$61.5M
Q1 25
$91.6M
Q4 24
$-3.2M
$506.6M
Q3 24
$1.9M
$453.1M
Q2 24
$34.1M
$492.7M
Q1 24
$45.0M
$649.0M
Total Assets
CMBM
CMBM
PACB
PACB
Q4 25
$784.1M
Q3 25
$803.2M
Q2 25
$825.5M
Q1 25
$860.8M
Q4 24
$173.7M
$1.3B
Q3 24
$194.3M
$1.5B
Q2 24
$221.1M
$1.5B
Q1 24
$219.8M
$1.7B
Debt / Equity
CMBM
CMBM
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
36.12×
Q2 24
2.02×
Q1 24
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
PACB
PACB
Operating Cash FlowLast quarter
$-10.4M
$-19.1M
Free Cash FlowOCF − Capex
$-10.8M
$-19.9M
FCF MarginFCF / Revenue
-26.8%
-44.6%
Capex IntensityCapex / Revenue
1.1%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
PACB
PACB
Q4 25
$-19.1M
Q3 25
$-18.7M
Q2 25
$-29.4M
Q1 25
$-44.1M
Q4 24
$-10.4M
$-30.6M
Q3 24
$8.9M
$-45.5M
Q2 24
$2.4M
$-54.3M
Q1 24
$-15.9M
$-75.7M
Free Cash Flow
CMBM
CMBM
PACB
PACB
Q4 25
$-19.9M
Q3 25
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-10.8M
$-32.3M
Q3 24
$6.8M
$-46.3M
Q2 24
$87.0K
$-55.7M
Q1 24
$-17.4M
$-79.6M
FCF Margin
CMBM
CMBM
PACB
PACB
Q4 25
-44.6%
Q3 25
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-26.8%
-82.3%
Q3 24
15.2%
-115.7%
Q2 24
0.2%
-154.8%
Q1 24
-37.0%
-205.0%
Capex Intensity
CMBM
CMBM
PACB
PACB
Q4 25
1.9%
Q3 25
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
1.1%
4.1%
Q3 24
4.8%
2.0%
Q2 24
5.1%
4.1%
Q1 24
3.3%
10.0%
Cash Conversion
CMBM
CMBM
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons